Thrombopoietin treatment of one graft in a double cord blood transplant provides early platelet recovery while contributing to long-term engraftment in NSG mice

Stem Cells and Development

Volumn 24, Issue 1, 2015, Pages 67-76

  Van Der Garde, Mark ^a,b   Van Hensbergen, Yvette ^a   Brand, Anneke ^a,c   Slot, Manon C ^a   De Graaf Dijkstra, Alice ^a   Mulder, Arend ^c   Watt, Suzanne M ^b   Zwaginga, Jaap Jan ^a,c  

^a CENTRAL LABORATORY   (Netherlands)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; THROMBOPOIETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CHIMERA; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; ENGRAFTMENT; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IN VITRO STUDY; LEUKOCYTE COUNT; LEUKOPOIESIS; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; SPLEEN; THROMBOCYTE COUNT; THROMBOCYTOPOIESIS; ANIMAL; BLOOD; DRUG EFFECTS; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMAN; MALE; METABOLISM; THROMBOCYTE; TIME FACTOR; XENOGRAFT;

MURINAE; MUS;

ANIMALS; BLOOD PLATELETS; CORD BLOOD STEM CELL TRANSPLANTATION; GRAFT SURVIVAL; HETEROGRAFTS; HUMANS; MALE; MICE; PLATELET COUNT; THROMBOPOIETIN; TIME FACTORS; TRANSPLANTATION CHIMERA;

EID: 84919782092     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0294     Document Type: Article

References (58)

1. Ballen KK, E Gluckman and HE Broxmeyer. (2013). Umbilical cord blood transplantation: the first 25 years and beyond. Blood 122:491-498.
2. Watt SM. (2014). Umbilical Cord Blood Banking. Reference Module in Biomedical Sciences. Caplan MJ, editor in chief. Elsevier Press, Kidligton, United Kingdom, Article 04238.
3. Ballen KK, J Koreth, YB Chen, BR Dey and TR Spitzer. (2012). Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant. Blood 119:1972-1980.
4. Fuchs E, PV O'Donnell and CG Brunstein. (2013). Alternative transplant donor sources: is there any consensus? Curr Opin Oncol 25:173-179.
5. Hidalgo A and PS Frenette. (2005). Enforced fucosylation of neonatal CD34 + cells generates selectin ligands that enhance the initial interactions with microvessels but not homing to bone marrow. Blood 105:567-575.
6. Xia L, JM McDaniel, T Yago, A Doeden and RP McEver. (2004). Surface fucosylation of human cord blood cells augments binding to P-selectin and E-selectin and enhances engraftment in bone marrow. Blood 104:3091-3096.
7. Hoggatt J, KS Mohammad, P Singh and LM Pelus. (2013). Prostaglandin E2 enhances long-term repopulation but does not permanently alter inherent stem cell competitiveness. Blood 122:2997-3000.
8. Page KM, A Mendizabal, B Betz-Stablein, S Weas, K Shoulars, T Gentry, VK Prasad, J Sun, S Carter, AE Balber and J Kurtzberg. (2014). Optimizing donor selection for public cord blood banking: influence of maternal, infant, and collection characteristics on cord blood unit quality. Transfusion 54:340-352.
9. Page KM, L Zhang, A Mendizabal, S Wease, S Carter, K Shoulars, T Gentr, AE Balber and J Kurtzberg. (2012). The cord blood Apgar: a novel scoring system to optimize selection of banked cord blood grafts for transplantation (CME). Transfusion 52:272-283.
10. Page KM, L Zhang, A Mendizabal, S Wease, S Carter, T Gentry, AE Balber and J Kurtzberg. (2011). Total colonyforming units are a strong, independent predictor of neutrophil and platelet engraftment after unrelated umbilical cord blood transplantation: a single-center analysis of 435 cord blood transplants. Biol Blood Marrow Transplant 17:1362-1374.
11. Barker JN, A Scaradavou and CE Stevens. (2010). Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies. Blood 115:1843-1849.
12. Terakura S, E Azuma, M Murata, T Kumamoto, M Hirayama, Y Atsuta, Y Kodera, M Yazaki, T Naoe and K Kato. (2007). Hematopoietic engraftment in recipients of unrelated donor umbilical cord blood is affected by the CD34 + and CD8 + cell doses. Biol Blood Marrow Transplant 13:822-830.
13. Lemarie C, B Esterni, B Calmels, B Dazey, V Lapierre, L Lecchi, A Meyer, D Rea, I Thuret, et al. (2007). CD34 + progenitors are reproducibly recovered in thawed umbilical grafts, and positively influence haematopoietic reconstitution after transplantation. Bone Marrow Transplant 39:453-460.
14. Wagner JE, JN Barker, TE DeFor, KS Baker, BR Blazar, C Eide, A Goldman, J Kersey, W Krivit, et al. (2002). Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatmentrelated mortality and survival. Blood 100:1611-1618.
15. Migliaccio AR, JW Adamson, CE Stevens, N Dobrila, CM Carrier and P Rubinstein. (2000). Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 96:2717-2722.
16. Scaradavou A, KM Smith, R Hawke, A Schaible, M Abboud, NA Kernan, JW Young and JN Barker. (2010). Cord blood units with low CD34 + cell viability have a low probability of engraftment after double unit transplantation. Biol Blood Marrow Transplant 16:500-508.
17. Avery S, W Shi, M Lubin, AM Gonzales, G Heller, H Castro-Malaspina, S Giralt, NA Kernan, A Scaradavou and JN Barker. (2011). Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts. Blood 117:3277-3285.
18. Scaradavou A, CG Brunstein, M Eapen, J Le-Rademacher, JN Barker, N Chao, C Cutler, C Delaney, F Kan, et al. (2013). Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia. Blood 121:752-758.
19. Oran B. (2012). Can double-cord transplants provide a more potent graft-vs-leukemia effect? Best Pract Res Clin Haematol 25:479-482.
20. Brunstein CG, JA Gutman, DJ Weisdorf, AE Woolfrey, TE DeFor, TA Gooley, MR Verneris, FR Appelbaum, JE Wagner and C Delaney. (2010). Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood. Blood 116:4693-4699.
21. Verneris MR, CG Brunstein, J Barker, ML MacMillan, T DeFor, DH McKenna, MJ Burke, BR Blazar, JS Miller and PB McGlave. (2009). Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units. Blood 114:4293-4299.
22. Ramirez P, J Wagner, T DeFor, C Eide, J Miller, D Weisdorf and C Brunstein. (2013). CXCR4 expression in CD34 + cells and unit predominance after double umbilical cord blood transplantation. Leukemia 27:1181-1183.
23. Dahlberg A, C Delaney and ID Bernstein. (2011). Ex vivo expansion of human hematopoietic stem and progenitor cells. Blood 117:6083-6090.
24. Kelly S, C Sola, M De Lima and E Shpall. (2009). Ex vivo expansion of cord blood. Bone Marrow Transplant 44:673-681.
25. de Lima M, I McNiece, SN Robinson, M Munsell, M Eapen, M Horowitz, A Alousi, R Saliba, JD McMannis and I Kaur. (2012). Cord-blood engraftment with ex vivo mesenchymal-cell coculture. N Engl J Med 367:2305-2315.
26. Delaney C, S Heimfeld, C Brashem-Stein, H Voorhies, RL Manger and ID Bernstein. (2010). Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med 16:232-236.
27. Horwitz ME, NJ Chao, DA Rizzieri, GD Long, KM Sullivan, C Gasparetto, JP Chute, A Morris, C McDonald, et al. (2014). Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment. J Clin Invest 124:3121-3128.
28. Cutler C, P Multani, D Robbins, HT Kim, T Le, J Hoggatt, LM Pelus, C Desponts, YB Chen, et al. (2013). Prostaglandinmodulated umbilical cord blood hematopoietic stem cell transplantation. Blood 122:3074-3081.
29. Farag SS, S Srivastav, S Messina-Graham, J Schwartz, MJ Robertson, R Abonour, K Cornetta, L Wood, A Secrest, et al. (2013). In vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignancies. Stem Cells Dev 22:1007-1015.
30. Christopherson KW 2nd, G Hangoc, CR Mantel and HE Broxmeyer. (2004). Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 305:1000-1003.
31. Broxmeyer HE, J Hoggatt, HA O'Leary, C Mantel, BR Chitteti, S Cooper, S Messina-Graham, G Hangoc, S Farag, et al. (2012). Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis. Nat Med 18:1786-1796.
32. Danby R and V Rocha. (2014). Improving engraftment and immune reconstitution in umbilical cord blood transplantation. Front Immunol 5:68-72.
33. Guttridge MG, TG Soh, H Belfield, C Sidders and SM Watt. (2014). Storage time affects umbilical cord blood viability. Transfusion 54:1278-1285.
34. de Sauvage FJ, K Carver-Moore, SM Luoh, A Ryan, M Dowd, DL Eaton, MW Moore. (1996). Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med 183:651-656.
35. Yoshihara H, F Aria, K Hosokawa, T Hagiwara, K Takubo, Y Nakamura, Y Gomei, H Iwasaki, S Matsuoka, et al. (2007). Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. Cell Stem Cell 1:685-697.
36. Qian H, N Buza-Vidas, CD Hyland, CT Jensen, J Antonchuk, R Mansson, LA Thoren, M Ekblom, WS Alexander and SEW Jacobsen. (2007). Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells. Cell Stem Cell 1:671-684.
37. Kuter DJ. (2013). The biology of thrombopoietin and thrombopoietin receptor agonists. Int J Hematol 98:10-23.
38. Yagi M, KA Ritchie, E Sitnicka, C Storey, GJ Roth and S Bartelmez. (1999). Sustained ex vivo expansion of hematopoietic stem cells mediated by thrombopoietin. Proc Natl Acad Sci USA 96:8126-8131.
39. Ng AP, M Kauppi, D Metcalf, CD Hyland, EC Josefsson, M Lebois, JG Zhang, TM Baldwin, L Di Rago, DJ Hilton and WS Alexander. (2014). Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation. Proc Natl Acad Sci USA 111:5884-5889.
40. Ng AP, M Kauppi, D Metcalf, L Di Rago, CD Hyland and WS Alexander. (2012). Characterization of thrombopoietin (TPO)-responsive progenitor cells in adult mouse bone marrow with in vivo megakaryocyte and erythroid potential. Proc Natl Acad Sci USA 109:2364-2369.
41. Sanjuan-Pla A, IC Macaulay, CT Jensen, PS Woll, TC luis, A Mead, S Moore, C Carella, S Matsuoka, et al. (2013). Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy. Nature 502:232-236.
42. Mattia G, L Milazzo, F Vulcano, M Pascuccio, G Macioce, HJ Hassan and A Giampaolo. (2008). Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34 + cells, thrombopoietin-amplified in clinical grade serum-free culture. Exp Hematol 36:244-252.
43. Schipper LF, A Brand, N Reniers, CJ Melief, R Willemze and WE Fibbe. (2003). Differential maturation of megakaryocyte progenitor cells from cord blood and mobilized peripheral blood. Exp Hematol 31:324-330.
44. van Hensbergen Y, LF Schipper, A Brand, MC Slot, M Welling, AJ Nauta and WE Fibbe. (2006). Ex vivo culture of human CD34 + cord blood cells with thrombopoietin (TPO) accelerates platelet engraftment in a NOD/SCID mouse model. Exp Hematol 34:943-950.
45. Bolwell B, B Pohlman, R Sobecks, S Andresen, S Brown, L Rybicki, V Wentling and M Kalaycio. (2004). Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplant. Bone Marrow Transplant 33:419-423.
46. Sutherland DR, L Anderson, M Keeney, R Nayar and I Chin-Yee. (1996). The ISHAGE guidelines for CD34 + cell determination by flow cytometry. J Hematother 5:213-226.
47. Schipper LF, Y van Hensbergen, WE Fibbe and A Brand. (2007). A sensitive quantitative single-platform flow cytometry protocol to measure human platelets in mouse peripheral blood. Transfusion 47:2305-2314.
48. van Hensbergen Y, A Mulder, JJ Cornelissen and A Brand. (2013). Validation of human monoclonal HLA Class I antibodies to evaluate the kinetics of donor chimerism in different cell subsets after double-cord blood transplantation in the NOD/SCID model. Transfusion 53:104-114.
49. Mulder A, MJ Kardol, JS Arn, C Eijsink, ME Franke, GM Schreuder, GW Haasnoot, II Doxiadis, DH Sachs and DM Smith. (2010). Human monoclonal HLA antibodies reveal interspecies crossreactive swine MHC class I epitopes relevant for xenotransplantation. Mol Immunol 47:809-815.
50. Somers JA, A Brand, Y van Hensbergen, A Mulder, M Oudshoorn, K Sintnicolaas, J-W Gratama, J Falkenburg, E Braakman and JJ Cornelissen. (2013). Double umbilical cord blood transplantation: A study of early engraftment kinetics in leukocyte subsets using HLA-specific monoclonal antibodies. Biol Blood Marrow Transplant 19:266-273.
51. Schipper LF, A Brand, WE Fibbe and Y Van Hensbergen. (2012). Functional characterization of TPO-expanded CD34 + cord blood cells identifies CD34-CD61-cells as plateletproducing cells early after transplantation in NOD/SCID mice and rCD34 + cells as CAFC colony-forming cells. Stem Cells 30:988-996.
52. Breems D, E Blokland, S Neben and R Ploemacher. (1994). Frequency analysis of human primitive haematopoietic stem cell subsets using a cobblestone area forming cell assay. Leukemia 8:1095.
53. Wallet HL, M Sobh, S Morisset, M Robin, N Fegueux, S Fürst, M Mohty, E Deconinck, L Fouillard and P Bordigoni. (2014). Double umbilical cord blood transplantation for hematological malignancies: a long-term analysis from the SFGM-TC registry. Exp Hematol 42:161-162.
54. Bruno B, T Gooley, KM Sullivan, C Davis, WI Bensinger, R Storb and RA Nash. (2001). Secondary failure of platelet recovery after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 7:154-162.
55. Gekas C and T Graf. (2014). CD41 expression marks myeloidbiased adult hematopoietic stem cells and increases with age. J Exp Med 211:217-231.
56. Shin JY, W Hu, M Naramura and CY Park. (2013). High c-Kit expression identifies hematopoietic stem cells with impaired self-renewal and megakaryocytic bias. Blood 121: 4463-4472.
57. Laurenti E, S Doulatov, S Zand, I Plumb, J Chen, C April, JB Fan and JE Dick. (2013). The transcriptional architecture of early human hematopoiesis identifies multilevel control of lymphoid commitment. Nat Immunol 14:756-763.
58. Görgens A, S Radtke, M Möllmann, M Cross, J Dürig, PA Horn and B Giebel. (2013). Revision of the human hematopoietic tree: granulocyte subtypes derive from distinct hematopoietic lineages. Cell Rep 3:1539-1552.